Literature DB >> 27601892

A randomized controlled trial of telephone-mentoring with home-based walking preceding rehabilitation in COPD.

Helen Laura Cameron-Tucker1, Richard Wood-Baker1, Lyn Joseph1, Julia A Walters1, Natalie Schüz2, E Haydn Walters1.   

Abstract

PURPOSE: With the limited reach of pulmonary rehabilitation (PR) and low levels of daily physical activity in chronic obstructive pulmonary disease (COPD), a need exists to increase daily exercise. This study evaluated telephone health-mentoring targeting home-based walking (tele-rehab) compared to usual waiting time (usual care) followed by group PR. PATIENTS AND METHODS: People with COPD were randomized to tele-rehab (intervention) or usual care (controls). Tele-rehab delivered by trained nurse health-mentors supported participants' home-based walking over 8-12 weeks. PR, delivered to both groups simultaneously, included 8 weeks of once-weekly education and self-management skills, with separate supervised exercise. Data were collected at three time-points: baseline (TP1), before (TP2), and after (TP3) PR. The primary outcome was change in physical capacity measured by 6-minute walk distance (6MWD) with two tests performed at each time-point. Secondary outcomes included changes in self-reported home-based walking, health-related quality of life, and health behaviors.
RESULTS: Of 65 recruits, 25 withdrew before completing PR. Forty attended a median of 6 (4) education sessions. Seventeen attended supervised exercise (5±2 sessions). Between TP1 and TP2, there was a statistically significant increase in the median 6MWD of 12 (39.1) m in controls, but no change in the tele-rehab group. There were no significant changes in 6MWD between other time-points or groups, or significant change in any secondary outcomes. Participants attending supervised exercise showed a nonsignificant improvement in 6MWD, 12.3 (71) m, while others showed no change, 0 (33) m. The mean 6MWD was significantly greater, but not clinically meaningful, for the second test compared to the first at all time-points.
CONCLUSION: Telephone-mentoring for home-based walking demonstrated no benefit to exercise capacity. Two 6-minute walking tests at each time-point may not be necessary. Supervised exercise seems essential in PR. The challenge of incorporating exercise into daily life in COPD is substantial.

Entities:  

Keywords:  exercise; physical capacity; pulmonary rehabilitation; self-reported walking; structured self-management-based education

Mesh:

Year:  2016        PMID: 27601892      PMCID: PMC5003521          DOI: 10.2147/COPD.S109820

Source DB:  PubMed          Journal:  Int J Chron Obstruct Pulmon Dis        ISSN: 1176-9106


Introduction

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition with systemic effect,1 exacting a substantial burden of increasing breathlessness and physical restrictions on individuals.2 This is of concern, as more physically active people with COPD have a lower risk of hospitalization and all-cause mortality3 and these individuals experience better physiologic function.4 Pulmonary rehabilitation (PR) is an intervention shown to help people with COPD improve their physical and psychosocial health, and is advocated as an integral component of COPD management.5,6 Supervised exercise is regarded as a key component of PR. Those who participate in conventional PR can expect an improvement in their physical capacity, health-related quality of life, breathlessness, and fatigue.7 However, the effect on daily physical activity levels in the community has only recently been investigated and appears to be minimal.8 The Australian Government defines “physical activity” as skeletal bodily movement resulting in ongoing health benefits, and “exercise” as a subset of physical activity, purposefully planned to maintain or improve physical health.9 “Physical capacity” refers to a person’s overall ability to function and “undertake the physically demanding activities of daily living”.10 These distinctions are important. One major outcome of PR is an improvement in physical capacity. While this may correlate with daily physical activity,11 formal physical capacity measures alone cannot reveal whether an individual is meeting recommended physical activity guidelines for health. Indeed, the literature indicates that people with COPD are predominantly sedentary,12 with exercise guidelines not being met.11 Despite the benefits of PR, its reach is limited. Internationally ~1% of people with COPD have access to PR.13 Australian data reflect this, with 200 programs available nationwide, predominantly based in health care facilities and accessed by only 1% of those who might benefit.14 Others have sought to increase the reach of interventions for people with COPD with promising technologies, such as brief telephone support,15 mobile telephone programs,16 or the computer-based Nintendo Wii Fit.17 Similarly, weekly reported diary-recorded home-walking has increased physical capacity compared to usual care.18 Strategies that foster self-management for sustained behavior change via telephone health-mentoring have been investigated.19,20 Self-management is a process that facilitates an individual’s confidence and capability to engage in health-promoting behaviors in order to deal with the impact of their condition on all aspects of their health-namely, a sense of self, physical, emotional, social and medical domains so as to maximize function and quality of life.21 Working with people to develop self-management skills is recognized as integral to PR6 and could even be an alternative to formal supervised exercise sessions. Telephone health-mentoring trials to improve self-management in COPD using community nurses improved health-related quality of life20 and self-management capacity.19 However, the effect on physical capacity or physical activity was not examined, which is important given the increasing focus on physical activity in COPD.22,23 One self-management approach that has reported improvements in self-reported physical activity is the group-based Stanford Chronic Disease Self-Management Program (CDSMP).24 We recently investigated the addition of an hour of supervised exercise to the CDSMP for people with COPD in a randomized controlled clinical trial, finding a small statistically significant increase in physical capacity.21 However, the increase of 20 m was less than half that reported in a review of traditional PR7 and less than the accepted minimal clinical important difference reported by others.25,26 We found no difference between the intervention and control groups for self-reported physical activity. To better meet clinical demand for PR, augmenting the gains we observed in the CDSMP21 and with telephone-based self-management support in COPD19,20 hold promise. In this study, we investigated the effects of telephone-based health-mentoring (tele-rehab) targeting home-based walking on physical capacity and self-reported physical activity.

Materials and methods

Study design

This parallel-group randomized clinical trial in COPD aimed to evaluate the effectiveness of tele-rehab followed by PR versus usual care, that is, a waiting period followed by the same PR. The primary outcome was physical capacity measured by the 6-minute walk distance (6MWD).27 The minimally important clinical difference (MICD) for the 6MWD at the time of our study was 35 m (95% confidence interval 30–42 m).28 In a recent study, we found the standard deviation of the change in distance walked was 46.2 m21 and the attrition rate in our rehabilitation program was 33%. Using these data, we calculated that the study would need to recruit 37 participants in each arm (power =0.8, significance =0.05) to demonstrate potential superiority of the intervention. Participants were assigned a unique identification number and randomized to the tele-rehab (intervention) or to usual care (control) group using computer-generated random numbers by a research assistant not associated with the study, ensuring neutral allocation after baseline data collection. The trial was registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12611001034921).

Study subjects

Following a hospital admission or clinic visit, adults with COPD, who were referred for PR at the Royal Hobart Hospital, a tertiary, university-affiliated public hospital, were screened and recruited. Referring staff were aware that this study was taking place. Individuals were included in the study if they were over 18 years of age, had spirometry-diagnosed COPD, and were at least 2 months post an exacerbation prior to data collection. They were excluded if they experienced cognitive impairment, were unable to provide informed consent, could not complete questionnaires independently, did not meet safety to exercise criteria,29 or had attended some form of PR in the previous 2 years. For those people not wishing to participate in the project or who did not meet the inclusion criteria, follow-up management, including referral to a physiotherapist or PR, was offered in the course of usual care.

Detail of interventions

Screening of initial referrals confirming general study suitability (age, diagnosis, comorbidities) was followed by a telephone invitation to attend an appointment. Following informed consent, inclusion criteria were confirmed, and baseline data collected (time-point 1, TP1). The next data collection was at 8 to 12 weeks, after either tele-rehab or the usual waiting time (time-point 2, TP2), and the final data collection was after 8 weeks of PR (time-point 3, TP3). Tele-rehab aimed to specifically support participants in undertaking exercise as well as address other mutually identified health behaviors from smoking, nutrition, alcohol consumption, physical activity, psychosocial well-being, and symptom management (“SNAPPS”).30,31 Following randomization, participants in the intervention group completed a summary of their SNAPPS health behaviors with the research officer and established a home-based walking plan, aiming to meet Australian guidelines at the time of the study: to walk at a moderate intensity (ie, to breathe more heavily but not to “huff and puff”) to accumulate 30 minutes daily on several and preferably all days of the week.32 They received a copy of their written personal walking action plan, their personal SNAPPS summary, plus information concerning health behaviors (Supplementary material). Participants were contacted via telephone by specifically trained community nurses19,20,33 who acted as nurse health-mentors over the next 8–12 weeks, to support the home-walking action plan and any other health behavior plans. A schedule of two calls weekly was suggested, with a minimum of four calls mutually agreed with each participant, based on findings in a previous study that indicated participants preferred a flexible schedule for health-mentoring contacts.20 Participants in usual care waited for 8 to 12 weeks prior to their scheduled PR appointment without any additional contact, reflecting the Australian context of PR.34 At the time of this study, the local Tasmanian waiting time was >3 months. PR followed the format of our previous study, consisting of 1 hour, once-weekly of 8 weeks of structured group education with self-management skills development (the CDSMP) and 1 hour of gym-based weekly supervised exercise.21 Supervised exercise was delivered in the same week but on a subsequent day to the education sessions. Individualized programs of aerobic exercise (aiming for at least 30 minutes of bicycle or treadmill exercise) with strengthening and stretching at a moderate to strong intensity determined and monitored by self-reported perception of exertion were developed. A discussion session targeting exercise and physical activity was offered with the education sessions. Participants reported back at the commencement of each session on their diary-recorded home-walking plans set the previous week. Participants and community nurses gave written, informed consent. The Tasmanian Human Research Ethics Committee granted ethical approval (H0011764).

Outcome measures and data analyses

Outcome measurements were blinded. The primary outcome was change in physical capacity, measured by the 6MWD,27 conducted according to standard Australian protocols. Two tests were performed at each time-point, with the longest distance of the two being recorded.35 Secondary outcomes are described in Table 1. Data pertaining to self-reported physical activity are presented as: 1) data from the SNAPPS snapshot questionnaire, that is, a retrospective report of habitual moderate intensity walking (how many days per week and minutes per day performed on average over the previous 4 weeks) and 2) data from the walking diary-recorded in real time during PR. The first measure reflects the usual enquiry about physical activity in our clinical practice.
Table 1

Outcomes and measures

OutcomesMeasures
Primary outcome
Physical capacity6MWD, a field walking test27
Secondary outcomes
Health-related quality of lifeCAT (0–40, 0= best)48
Health behaviors“SNAPPS” snapshot questionnaire (total score 0–60, 60= best; domain score 0–10, 10= best)
Physical activity (1)Self-reported walking (retrospective report) from SNAPPS snapshot questionnaire, Physical activity domain: Days per week Minutes per day
Physical activity (2)Home-based walking action plan recorded in a personal walking diary (self-recorded in real time)

Notes: We had planned to measure hospital admissions but there were insufficient data obtainable. Data were collected regarding participant and mentor experiences but are not reported here. (1) =First measure of physical activity; (2) =second measure of physical activity.

Abbreviations: 6MWD, 6-minute walk test distance; CAT, COPD assessment Test; COPD, chronic obstructive pulmonary disease; SNAPPS, smoking, nutrition, alcohol consumption, physical activity, psychosocial well-being, and symptom management.

Analysis was by intention-to-treat, missing data handled by last case carried forward, and comparisons made using Mann–Whitney U-tests, Student’s t-tests, or chi-squared analyses. Correlations were investigated using Pearson’s correlation coefficient. Significance was set at a P-value of <0.05. Blinding with respect to participant allocation was maintained until data analyses were complete.

Results

Participants

Recruiting took place over 15 months from February 2012 (Figure 1). Of the 362 individuals referred, most (73%) were inpatients referred by the respiratory nurse specialist or physiotherapists, with 23% referred directly by respiratory physicians, 4% by general practitioners and community nurses, and 3% by other hospital ward-based doctors. Of the 297 not included in the study, nearly two-thirds declined an appointment, citing health or travel issues as the main barrier to attendance (Figure 1). Although we had planned to recruit 74 individuals, we made a decision to cease recruiting in order to complete the follow-up TP3 assessments as scheduled. Thus, 65 participants were randomized, 35 to the intervention and 30 to the control groups, respectively. No participant changed groups during follow-up.
Figure 1

Flowchart depicting flow of participants through the study.

Abbreviations: COPD, chronic obstructive pulmonary disease; PR, pulmonary rehabilitation.

Of those 65 individuals randomized, 25 (38%) withdrew (12 interventions and 13 controls) during the study, with males (n=17, 68%) being more likely to withdraw than females (P=0.005). The majority withdrew prior to PR commencing (ten in intervention and ten controls). “Ill health” was named by nearly half as the reason for withdrawing, time constraints by a quarter, with the remainder citing travel issues, giving no reason, or just failure to keep appointments. Eighteen trained nurses delivered the mentoring for tele-rehab. There were a total of 231 telephone contacts, with a mean of 7±3 calls per individual, each lasting a duration of 17±9 minutes per call and 7±6 days between calls. Contact with tele-rehab participants could not be made on 38 occasions and data were not recorded for 18 calls. Of 287 walking action plans set, 48% were completed, 27% not completed, and 25% not recorded. The principle reasons for not completing the walking program were being unwell or time constraints. At the first PR session, only 31 (74%) of the 42 participants remaining by this stage expressed intention to attend the supervised exercise sessions, despite all having consented to do so at recruitment. However, only 16 (38%) actually commenced supervised exercise (ten in intervention and six controls), attending only a mean of 5±2 sessions of a possible eight. A preference to exercise at home was stated as the main reason for not commencing supervised exercise, followed by travel issues. Of those who commenced supervised exercise, a greater proportion was female (75%), did not have a partner (63%), had moderate or severe COPD (82%), and were in the intervention group (63%). A median of 6 (4) sessions were attended, with ill health cited as the predominant reason for nonattendance. At baseline, there were no statistically significant differences between the intervention and control group subjects for demographic (Table 2) or outcome (Table 3) measures, or between those who withdrew and those who completed all data collections.
Table 2

Participant characteristics

VariableParticipants (n=65)Intervention (n=35)Control (n=30)P-value (I versus C)
Female36 (55%)19 (54%)17 (57%)0.52
Age (years)69±8.668±9.970±6.80.49
Married31 (48%)19120.18
Years of education10 (3)10 (3)10 (3)0.99
Referral source
Physiotherapist, respiratory nurse (public hospital ward)37 (57%)20 (57%)17 (57%)
Respiratory physicians (public and private practice)26 (40%)13 (37%)13 (43%)0.40
Community (doctors, other)2 (3%)2 (6%)0
Body mass index (m2/kg)27±6.8 (n=63)27±5.9 (n=34)28±7.7 (n=29)0.48
COPD severity
Mild (FEV1 >80%)4 (6%)3 (9%)1 (3%)0.46
Moderate (FEV1 59%–79%)22 (34%)12 (34%)10 (33%)
Severe (FEV1 30%–49%)24 (37%)10 (29%)14 (47%)
Very severe (FEV1 <30%)8 (12%)6 (17%)2 (7%)
Missing data7 (11%)4 (11%)3 (10%)

Notes: Data are reported as either mean ± standard deviation, median (interquartile range), or raw number (percent) within study group status. The P-values are from student’s t-tests, Mann–Whitney U-tests, or chi-squared analyses. I = intervention, C = control with a level of significance P<0.05. COPD severity classified according to GOLD classification.1

Abbreviations: COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Chronic Obstructive Lung Disease; FEV1, forced expiratory volume in 1 second.

Table 3

Baseline outcomes: intervention versus control group

VariableIntervention (tele-rehab + PR phase) n=35Control (usual waiting time + PR phase) n=30P-value
6MWD (meters)333.3±120.9344.8±113.70.69
CAT, scale 0–4022±620±80.27
“SNAPPS” snapshot, scale 0–60n=34 38±7 (n=34)n=29 39±9 (n=29)0.78
SNAPPS snapshot domains scores, scale 0–10
Smoking10 (1)10 (0)0.50
Nutrition9 (5)8 (7)0.27
Alcohol10 (3)10 (4)0.81
Physical activity5 (8)0 (8)0.40
Psychosocial5±26±20.13
Symptom management5 (3)5 (3)0.16
SNAPPS snapshot self-reported walking
Days per week3 (5)0 (4)0.20
Minutes per day10 (30)3 (23)0.62

Notes: Data are reported as either mean ± standard deviation or median (interquartile range). The P-values are from student’s t-tests or Mann–Whitney U-tests with a level of significance P<0.05 for the primary outcome.

Abbreviations: 6MWD, 6-minute walk distance; CAT, COPD assessment test; COPD, chronic obstructive pulmonary disease; PR, pulmonary rehabilitation; SNAPPS, smoking, nutrition, alcohol consumption, physical activity, psychosocial well-being, and symptom management.

Primary outcome at different time-points

There was a significant difference between groups for the change in the 6MWD over the first time period between TP1 and TP2, that is the effect of Tele-Rehab or usual waiting time (median 0 versus 12 meters, P=0.01). Counterintuitively, while there was no change in the active intervention group, there was an increase in the distance walked by controls (Table 4). There was no difference for the PR phase (Table 4). The 16 who attended supervised exercise did demonstrate a median increase of 12.3 m from PR but this was not statistically significant or clinically meaningful. Those not attending supervised exercise showed no change at all.
Table 4

Changes in outcomes between groups: intervention group versus control group

VariableIntervention
Control
P-valueIntervention
Control
P-value
n=35 (effect of tele-rehab)
n=30 (effect of usual waiting time)
n=35 (effect of tele-rehab)
n=30 (effect of PR phase)
Change TP1/2Change TP1/2Change TP2/3Change TP2/3
Primary outcome
6MWD (meters)0 (41)12 (39)0.010 (23)0 (19)0.51
Secondary outcomes
CAT, scale 0–400 (6)0 (6)0.480 (3)0 (2)0.81
“SNAPPS” snapshot, scale 0–602 (6)1 (4)0.420 (5)0 (4)0.70
SNAPPS snapshot domains, scale 0–10
Smoking0 (0)0 (0)0.990 (0)0 (0)0.36
Nutrition0 (0)0 (0)0.9890 (0)0 (0)1.00
Alcohol0 (0)0 (0)0.280 (0)0 (0)0.74
Physical activity0 (4)0 (4)0.40 (1)0 (0)0.80
Psychosocial0 (0)0 (0)0.7370 (0)0 (0)0.47
Symptom management0 (1)0 (2)0.850 (2)0 (2)0.30
SNAPPS snapshot self-reported walking
Days per week0 (5)0 (0)0.640 (1)0 (1)0.81
Minutes per day14 (26)16 (40)0.1016 (23)17 (29)0.96

Notes: Data are reported as median (interquartile range). The P-values are from Mann–Whitney U-tests with a level of significance P<0.05. TP1/2= change between time-point 1 and time-point 2, TP2/3= change between time-point 2 to time-point 3. As there were no statistically or clinically significant changes between TP1 and TP3, we report the effect of tele-rehab, usual waiting time, and PR phase.

Abbreviations: 6MWD, 6-minute walk distance; CAT, COPD assessment test; COPD, chronic obstructive pulmonary disease; PR, pulmonary rehabilitation; SNAPPS, smoking, nutrition, alcohol consumption, physical activity, psychosocial well-being, and symptom management.

A statistically significant difference between the two walking tests was apparent at each time-point (Table 5). Approximately two-thirds of the group walked a small distance further on the second walking test.
Table 5

Comparison of two 6-minute walk test distances conducted 30 minutes apart at different time-points

Time-point (TP)Walk distance 1Walk distance 2Change in distanceP-value
TP1318.2±116.4331.6±119.413.5±41.00.01
TP2331.3±112.4346.4±117.115.2±28.0<0.001
TP3338.4±111.5346.8±117.08.4±28.00.02

Notes: Data are reported as mean ± standard deviation. The P-values are from student’s t-tests. Walk distance is measured in meters. number of participants =65. Time-point 1, baseline; time-point 2, after 8–12 weeks of tele-rehab or usual waiting time; time-point 3, after 8 weeks of pulmonary rehabilitation phase.

Secondary outcomes

There were no statistically significant differences between the groups in any of the secondary outcomes (Table 4). Walking diary data revealed no differences between groups in real-time reported walking (Table 6), although only 24 walking diaries were returned from a possible 40. Similarly, the average days walked per week and the average minutes per day during the PR phase were much the same for the two groups. Only nine participants recorded barriers to home-walking (being unwell or inclement weather), and seven cited facilitators (walking with another or incorporating exercise into daily activities).
Table 6

Walking diary data: intervention versus controls; exercise attendees versus nonattendees

VariableIntervention (tele-rehab + PR phase) n=13Control (usual waiting time + PR phase) n=11P-valueSupervised exercise
P-value
Attendees, n=16Nonattendees, n=49
Week 1, beginning of group-rehab
Days per week5 (2)4 (6)0.305 (3)4 (3)0.87
Minutes per day27 (20)19 (23)0.0923 (17)20 (20)1.00
Average over 8 weeks of group-rehab
Days per week4±14±10.814±14±10.70
Minutes per day33±1829±80.5728±1034±180.30

Notes: Data are reported as either mean ± standard deviation or median (interquartile range). The P-values are from student’s t-tests or Mann–Whitney U-tests with a level of significance P<0.05 for the primary outcome. As there was no statistically or clinically significant difference between the intervention or control groups, we have also reported data for those attending supervised exercise and those who did not.

Abbreviation: PR, pulmonary rehabilitation.

Retrospectively reported walking (physical activity 1) showed a strong association with real-time recorded walking diary data (physical activity 2), with Pearson’s correlation coefficients (r) being 0.7 for days walked per week and 0.6 for minutes walked per day (P=0.001 and 0.002, respectively).

Discussion

Summary of results

This study investigated extending the reach of PR by using tele-rehab to increase home-based walking for exercise. We found no obvious objective improvement in the 6MWD for tele-rehab, or PR, with only controls demonstrating a very small and clinically nonmeaningful increase in 6MWD during the waiting period prior to PR. This is not easily explicable, and more likely represents measurement error, rather than a true effect. There were no changes in secondary outcomes. Although walking diaries correlated well with self-reported exercise, no differences between the intervention or control groups or those who commenced supervised exercise and those who did not were found. Analyses of the 6MWD data from the two tests conducted at the three time-points revealed a statistically significant but not clinically meaningful increase in distance walked during the second test.

6MWD and physical activity

We found limited evidence for the effectiveness of self-management support via telephone health-mentoring on physical capacity or self-directed exercise at home. Others have similarly concluded that self-management focusing on education36 or self-management per se has minimal effect on physical capacity.37 Our data support the conclusions of the latter authors that this is due to participants not exercising at sufficient intensity and, as our results indicate, not walking at a sufficient frequency. In contrast, in a recent cohort study of home-based PR with once weekly supervision, participants exercised for at least 5 days per week, for 30 to 45 minutes, and at a higher intensity than our participants did, resulting in a statistically and clinically significant increase in physical capacity.38 Thus, a more demanding program, if enforceable, could have produced better outcomes. It is possible that our tele-rehab intervention was not of sufficient duration or number of calls. A systematic review of telephone interventions for physical activity in adults, many with chronic conditions although not COPD, suggested that 12 or more calls over a 6–12-month period was effective in improving physical activity and dietary behavior.39 Our study fell short of this demanding schedule, being of only 2 months’ duration with an average of seven calls per individual. Additionally, many of our participants did not complete their walking plans (27%) because they were unwell. It may be that this strategy is just not feasible for those with moderate to severe COPD because of the degree of illness these people experience. Our data revealed a strong correlation between self-reported walking and diary-recorded walking, pointing to the validity of these questions routinely used in Australian physiotherapy clinical practice. This study has also reinforced the conclusions drawn from our previous study: a mere hour of supervised exercise added to the CDSMP (the structured education component of our PR approach) does not result in clinically important changes in physical capacity or self-reported physical activity.21 This was exacerbated by the low attendance rate at supervised exercise offered separately to the education component in the clinical facility where the study took place. Despite emphasizing the importance of the supervised exercise sessions, compliance even with commencing was low (38%), suggesting that participants may have perceived this to be an “optional extra”. Attendance at exercise sessions may have been improved if this was seen to be a priority and if the importance of supervised exercise was reinforced by peers.40 It is obviously necessary that participants understand that attending higher intensity supervised exercise is paramount5,6 and without this they cannot expect to experience the benefits of PR. Our study supports the wider literature that supervised exercise is an essential component of PR, and it is likely that exercise sessions of substantial intensity, occurring at least twice per week, are needed to improve physical capacity.5,6 This study lends support to the presence of a learning effect for the 6MWD.41 The proportion of people walking further in our study was approximately two-thirds at each of the three time-points, in contrast to the variability of 50%–87% reported in the Field Walking Tests Technical Standards.41 However, the increment was half that reported by others42 and while statistically significant, it is less than half the MICD.28 Nevertheless, this small change may be important, for example, in a situation where reaching a threshold distance for 6MWD determines suitability for interventions. We would then concur with Holland et al41 that conducting two walking tests and recording the longest distance is recommended. However, if the MICD is to be the benchmark by which efficacy is measured and not 6MWD per se, our results suggest that a second test is not really required.

Study limitations and implications for future practice and research

There were some limitations to our study. First, despite community nurses being trained in core self-management support skills (motivational interviewing,43 problem-solving,44 action planning,45 and communication skills), we do not know the extent of fidelity to the intervention. Recording of telephone calls was an intent but proved to be logistically difficult in practice and was discontinued. If this is to happen in trials set in clinical practice, the equipment must be simple and quickly performed. Second, the tele-rehab intervention may have been better delivered by health professionals, such as physiotherapists who are skilled in the management of exercise, movement, and function for people with COPD. Additionally, individuals may require prior experience of structured exercise as well as integrating this into daily activities.38 Future research may indicate how many supervised sessions are initially required. Third, walking plans may need to be a combination of health professional prescription and self-set criteria, rather than wholly self-set as in the CDSMP paradigm that this study followed; “tough love” may be required. Fourth, while we did address barriers to exercise and physical activity as they arose, we did not investigate illness or exercise perceptions, that is, how people with COPD perceive their condition and their ability to exercise. Perceptions about exercise have been positively correlated with physical capacity46 and the same may hold true for illness perceptions and response to PR. This should be addressed prior to PR commencing, as should issues, such as anxiety and depression, which have now been shown to influence physical activity.47 Furthermore, it was not possible to recruit the number of individuals suggested by the a priori power analyses during the duration of the study. Therefore, nonparametric tests were used where possible. However, due to small cell sizes, results of chi-square tests may not be accurate. Future studies may want to replicate results with larger sample sizes.

Conclusion

In this small but insightful study, there was no benefit to a tele-rehab phase prior to group-based PR. Structured education with self-management skills development (the CDSMP), diary-recorded walking plans, and 1 hour of weekly supervised exercise added little. Two 6MWD tests may not always be necessary, despite a small learning effect. Supervised exercise is a mandatory component of PR. However, ongoing incorporation of exercise into daily life is also essential and there is a huge challenge to achieving this in people with COPD.
  37 in total

1.  Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study.

Authors:  J Garcia-Aymerich; P Lange; M Benet; P Schnohr; J M Antó
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

Review 2.  An international comparison of pulmonary rehabilitation: a systematic review.

Authors:  Laura Desveaux; Tania Janaudis-Ferreira; Roger Goldstein; Dina Brooks
Journal:  COPD       Date:  2014-07-01       Impact factor: 2.409

Review 3.  Pulmonary rehabilitation for chronic obstructive pulmonary disease.

Authors:  Y Lacasse; R Goldstein; T J Lasserson; S Martin
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

4.  Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

Authors:  Fabio Pitta; Thierry Troosters; Martijn A Spruit; Vanessa S Probst; Marc Decramer; Rik Gosselink
Journal:  Am J Respir Crit Care Med       Date:  2005-01-21       Impact factor: 21.405

5.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

Authors:  G H Guyatt; M J Sullivan; P J Thompson; E L Fallen; S O Pugsley; D W Taylor; L B Berman
Journal:  Can Med Assoc J       Date:  1985-04-15       Impact factor: 8.262

6.  How should we measure function in patients with chronic heart and lung disease?

Authors:  G H Guyatt; P J Thompson; L B Berman; M J Sullivan; M Townsend; N L Jones; S O Pugsley
Journal:  J Chronic Dis       Date:  1985

7.  Acceptability and feasibility of pulmonary rehabilitation for COPD: a community qualitative study.

Authors:  Lynda Moore; Lauren Hogg; Patrick White
Journal:  Prim Care Respir J       Date:  2012-12

8.  Physical activity and clinical and functional status in COPD.

Authors:  Judith Garcia-Aymerich; Ignasi Serra; Federico P Gómez; Eva Farrero; Eva Balcells; Diego A Rodríguez; Jordi de Batlle; Elena Gimeno; David Donaire-Gonzalez; Mauricio Orozco-Levi; Jaume Sauleda; Joaquim Gea; Robert Rodriguez-Roisin; Josep Roca; Àlvar G Agustí; Josep M Antó
Journal:  Chest       Date:  2009-03-02       Impact factor: 9.410

9.  An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.

Authors:  Martijn A Spruit; Sally J Singh; Chris Garvey; Richard ZuWallack; Linda Nici; Carolyn Rochester; Kylie Hill; Anne E Holland; Suzanne C Lareau; William D-C Man; Fabio Pitta; Louise Sewell; Jonathan Raskin; Jean Bourbeau; Rebecca Crouch; Frits M E Franssen; Richard Casaburi; Jan H Vercoulen; Ioannis Vogiatzis; Rik Gosselink; Enrico M Clini; Tanja W Effing; François Maltais; Job van der Palen; Thierry Troosters; Daisy J A Janssen; Eileen Collins; Judith Garcia-Aymerich; Dina Brooks; Bonnie F Fahy; Milo A Puhan; Martine Hoogendoorn; Rachel Garrod; Annemie M W J Schols; Brian Carlin; Roberto Benzo; Paula Meek; Mike Morgan; Maureen P M H Rutten-van Mölken; Andrew L Ries; Barry Make; Roger S Goldstein; Claire A Dowson; Jan L Brozek; Claudio F Donner; Emiel F M Wouters
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

10.  Internet-based treatment for adults with depressive symptoms: the protocol of a randomized controlled trial.

Authors:  Lisanne Warmerdam; Annemieke van Straten; Pim Cuijpers
Journal:  BMC Psychiatry       Date:  2007-12-19       Impact factor: 3.630

View more
  16 in total

Review 1.  Integrated disease management interventions for patients with chronic obstructive pulmonary disease.

Authors:  Charlotte C Poot; Eline Meijer; Annemarije L Kruis; Nynke Smidt; Niels H Chavannes; Persijn J Honkoop
Journal:  Cochrane Database Syst Rev       Date:  2021-09-08

Review 2.  Self-management interventions for people with chronic obstructive pulmonary disease.

Authors:  Jade Schrijver; Anke Lenferink; Marjolein Brusse-Keizer; Marlies Zwerink; Paul Dlpm van der Valk; Job van der Palen; Tanja W Effing
Journal:  Cochrane Database Syst Rev       Date:  2022-01-10

Review 3.  Educational interventions for health professionals managing chronic obstructive pulmonary disease in primary care.

Authors:  Amanda J Cross; Dennis Thomas; Jenifer Liang; Michael J Abramson; Johnson George; Elida Zairina
Journal:  Cochrane Database Syst Rev       Date:  2022-05-06

4.  Physical Inactivity, Self-Management, and Living Well With COPD.

Authors:  David B Coultas
Journal:  Am J Lifestyle Med       Date:  2017-04-04

5.  Digital interventions for the management of chronic obstructive pulmonary disease.

Authors:  Sadia Janjua; Emma Banchoff; Christopher Jd Threapleton; Samantha Prigmore; Joshua Fletcher; Rebecca T Disler
Journal:  Cochrane Database Syst Rev       Date:  2021-04-19

6.  Telerehabilitation for chronic respiratory disease.

Authors:  Narelle S Cox; Simone Dal Corso; Henrik Hansen; Christine F McDonald; Catherine J Hill; Paolo Zanaboni; Jennifer A Alison; Paul O'Halloran; Heather Macdonald; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2021-01-29

7.  Evaluating a Web-Based Coaching Program Using Electronic Health Records for Patients With Chronic Obstructive Pulmonary Disease in China: Randomized Controlled Trial.

Authors:  Lan Wang; Lin He; Yanxia Tao; Li Sun; Hong Zheng; Yashu Zheng; Yuehao Shen; Suyan Liu; Yue Zhao; Yaogang Wang
Journal:  J Med Internet Res       Date:  2017-07-21       Impact factor: 5.428

8.  Does health coaching improve health-related quality of life and reduce hospital admissions in people with chronic obstructive pulmonary disease? A systematic review and meta-analysis.

Authors:  Hannah Long; Kelly Howells; Sarah Peters; Amy Blakemore
Journal:  Br J Health Psychol       Date:  2019-04-29

Review 9.  Blended Self-Management Interventions to Reduce Disease Burden in Patients With Chronic Obstructive Pulmonary Disease and Asthma: Systematic Review and Meta-analysis.

Authors:  Xiaoyue Song; Cynthia Hallensleben; Weihong Zhang; Zongliang Jiang; Hongxia Shen; Robbert J J Gobbens; Rianne M J J Van Der Kleij; Niels H Chavannes; Anke Versluis
Journal:  J Med Internet Res       Date:  2021-03-31       Impact factor: 5.428

10.  Self management of patients with mild COPD in primary care: randomised controlled trial.

Authors:  Kate Jolly; Manbinder S Sidhu; Catherine A Hewitt; Peter A Coventry; Amanda Daley; Rachel Jordan; Carl Heneghan; Sally Singh; Natalie Ives; Peymane Adab; Susan Jowett; Jinu Varghese; David Nunan; Khaled Ahmed; Lee Dowson; David Fitzmaurice
Journal:  BMJ       Date:  2018-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.